Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
2.071
+0.171 (9.00%)
May 12, 2025, 4:00 PM - Market closed
Nephros Market Cap
Nephros has a market cap or net worth of $21.95 million as of May 12, 2025. Its market cap has decreased by -4.96% in one year.
Market Cap
21.95M
Enterprise Value
19.20M
1-Year Change
-4.96%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $21.95M, a decrease of -59.42%. That is a compound annual growth rate of -14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 20.10M | 29.68% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |